drugset / Trial / NCT03154814

Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass

NCT03154814

Phase 4 Completed 80 enrolled Konkuk University Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Retrospective study determine whether ulinastatin enhances postoperative pulmonary oxygenation after cardiopulmonary bypass (CPB).

Timeline

Start
2016-01-01
Primary completion
2017-04-01
Completion
2017-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulinastatin Protein / enzyme biologic 5000 iu/kg